Dimitri Eye Care - Medicare Optometrist in Metairie, LA

Dimitri Eye Care is a medicare enrolled "Optometrist" provider in Metairie, Louisiana. Their current practice location is 701 Metairie Rd, Suite 205, Metairie, Louisiana. You can reach out to their office (for appointments etc.) via phone at (504) 837-3937.

Dimitri Eye Care is licensed to practice in Louisiana (license number 1098-052T) and it also participates in the medicare program. Dimitri Eye Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1629292941.

Contact Information

Dimitri Eye Care
701 Metairie Rd, Suite 205,
Metairie, LA 70005-4050
(504) 837-3937
(504) 837-2814



Healthcare Provider's Profile

Full NameDimitri Eye Care
TypeFacility
SpecialityOptometrist
Location701 Metairie Rd, Metairie, Louisiana
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1629292941
  • Provider Enumeration Date: 04/11/2007
  • Last Update Date: 08/22/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 2365576865
  • Enrollment ID: O20100819000717

Medical Identifiers

Medical identifiers for Dimitri Eye Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629292941NPI-NPPES
1440965MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 1098-052T (Louisiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Dimitri Eye Care acts as a billing entity for following providers:
Provider NameHenry Mifred Haley
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1972578516
PECOS PAC ID: 7012991284
Enrollment ID: I20070219000540

News Archive

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Cegedim Dendrite, the world leader in Customer Relationship Management solutions for the Pharmaceutical and Life Sciences industries, entered a five-year framework agreement with Pierre Fabre Laboratories, to strengthen and roll-out medical sales solutions to their international subsidiaries where Cegedim Dendrite solutions have not been implemented.

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

Indirubin might help treat glioblastoma

The active ingredient in a traditional Chinese herbal remedy might help treat deadly brain tumors, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

Read more Medical News

› Verified 6 days ago

Provider NameRonald George Dimitri
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1265491658
PECOS PAC ID: 4183740301
Enrollment ID: I20100924001150

News Archive

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Cegedim Dendrite, the world leader in Customer Relationship Management solutions for the Pharmaceutical and Life Sciences industries, entered a five-year framework agreement with Pierre Fabre Laboratories, to strengthen and roll-out medical sales solutions to their international subsidiaries where Cegedim Dendrite solutions have not been implemented.

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

Indirubin might help treat glioblastoma

The active ingredient in a traditional Chinese herbal remedy might help treat deadly brain tumors, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

Read more Medical News

› Verified 6 days ago

Provider NamePaul E Prouet
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1184686420
PECOS PAC ID: 5991968083
Enrollment ID: I20120530000481

News Archive

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Cegedim Dendrite, the world leader in Customer Relationship Management solutions for the Pharmaceutical and Life Sciences industries, entered a five-year framework agreement with Pierre Fabre Laboratories, to strengthen and roll-out medical sales solutions to their international subsidiaries where Cegedim Dendrite solutions have not been implemented.

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

Indirubin might help treat glioblastoma

The active ingredient in a traditional Chinese herbal remedy might help treat deadly brain tumors, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dimitri Eye Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dimitri Eye Care
701 Metairie Rd, Suite 205,
Metairie, LA 70005-4050

Ph: (504) 837-3937
Dimitri Eye Care
701 Metairie Rd, Suite 205,
Metairie, LA 70005-4050

Ph: (504) 837-3937

News Archive

Cegedim Dendrite signs five-year framework agreement with Pierre Fabre Laboratories

Cegedim Dendrite, the world leader in Customer Relationship Management solutions for the Pharmaceutical and Life Sciences industries, entered a five-year framework agreement with Pierre Fabre Laboratories, to strengthen and roll-out medical sales solutions to their international subsidiaries where Cegedim Dendrite solutions have not been implemented.

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

Indirubin might help treat glioblastoma

The active ingredient in a traditional Chinese herbal remedy might help treat deadly brain tumors, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

Read more News

› Verified 6 days ago


Optometrist in Metairie, LA

Geesala Garvin, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 3200 Severn Ave, Ste 102, Metairie, LA 70002
Phone: 504-887-2020    Fax: 504-887-7698
Dr. Thomas Terrell Mcginn Jr., O.D
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 4324 Veterans Memorial Blvd, Suite 104, Metairie, LA 70006
Phone: 504-455-9825    Fax: 504-883-7669
Mary Elizabeth Hood, OPTOMETRIST
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 1431 Veterans Memorial Blvd, Metairie, LA 70005
Phone: 504-837-8323    Fax: 504-837-7344
Langhetee Eye Center Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2201 Veterans Memorial Blvd Ste 402, Metairie, LA 70002
Phone: 504-777-7733    Fax: 504-648-1418
Myeyedr.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 3200 Severn Ave, Metairie, LA 70002
Phone: 504-541-9025    
Dr. James P Murphy, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 3409 N Hullen St, Metairie, LA 70002
Phone: 504-888-2600    Fax: 504-456-9596
Xuan T. Pham, O.d., Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3900 Airline Dr, Metairie, LA 70001
Phone: 504-831-3662    Fax: 504-831-8272

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.